Spector Marcelo, Mojibian Hamid, Eliseo Donna, Pollak Jeffrey S, Reiner Eric, Arici Melih, Tal Michael G
Interventional Radiology Section, VA Connecticut Healthcare System, 950 Campbell Ave, West Haven, CT 06516, USA.
J Vasc Interv Radiol. 2008 Oct;19(10):1434-8. doi: 10.1016/j.jvir.2008.06.018. Epub 2008 Aug 9.
To report the authors' clinical experience with the Tal Palindrome chronic dialysis catheter with a symmetric tip.
During a 39-month period, 126 Palindrome catheters were placed consecutively in 85 patients. Follow-up was available for 115 catheters. Insertion complications, patency, catheter-related bacteremia, exit site infections, and reasons for catheter removal were recorded. The patient's initial cause of end-stage renal disease, underlying diseases, and site of access were recorded as well.
Patient ranged in age from 35 to 91 years (median, 69 years). Fifty percent of patients had diabetes. One hundred twenty-six Palindrome catheters were placed for a total of 12,046 catheter-days. The technical success rate of catheter placement was 100%. The average catheter indwell time was 105 days (range, 1-673 days). Catheters were inserted via the right (n = 107) or left (n = 19) jugular vein in all patients without insertional complication. Catheter-related infections occurred in 16 of the 115 catheters (13.9%) during the study period and culture-proved bacteremia occurred in four (3.5%). Seven exit site infections were recorded, and 10 catheters (8.7%) developed fibrin sheaths that necessitated catheter exchanges.
Clinical experience with the Tal Palindrome hemodialysis catheter demonstrated safe and reliable use with low infection rates.
报告作者使用具有对称尖端的塔尔回文式慢性透析导管的临床经验。
在39个月的时间里，85例患者连续植入了126根回文式导管。对115根导管进行了随访。记录了插入并发症、通畅情况、导管相关菌血症、出口部位感染以及导管拔除原因。还记录了患者终末期肾病的初始病因、基础疾病和通路部位。
患者年龄在35至91岁之间（中位数为69岁）。50%的患者患有糖尿病。共植入126根回文式导管，累计导管日数为12046天。导管置入的技术成功率为100%。导管平均留置时间为105天（范围为1至673天）。所有患者均通过右侧颈静脉（n = 107）或左侧颈静脉（n = 19）插入导管，无插入并发症。在研究期间，115根导管中有16根（13.9%）发生了导管相关感染，4根（3.5%）发生了血培养证实的菌血症。记录到7例出口部位感染，10根导管（8.7%）形成了纤维蛋白鞘，需要更换导管。
塔尔回文式血液透析导管的临床经验表明其使用安全可靠，感染率低。
